Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review

BACKGROUND: Many clinical trials testing Ginkgo biloba extract EGb 761 in patients with mild forms of cognitive impairment were conducted before widely accepted terms and diagnostic criteria for such conditions were available. This makes it difficult to compare any results from earlier and more rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Hort, Jakub, Duning, Thomas, Hoerr, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041984/
https://www.ncbi.nlm.nih.gov/pubmed/36994422
http://dx.doi.org/10.2147/NDT.S401231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041984/
https://www.ncbi.nlm.nih.gov/pubmed/36994422
http://dx.doi.org/10.2147/NDT.S401231

Ejemplares similares